Registry for Systemic Eczema Treatments
Recruiting · NCT06136767 · Observational (researchers observe without assigning treatment) · Lead sponsor: Johns Hopkins University
View the official record on ClinicalTrials.gov →What this trial is about
The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.
Who can take part
Age range
1 Year to 26 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age \<26 years old
- Current physician diagnosis of atopic dermatitis
- Provide signed informed consent if ≥ 18 years old
- Provide signed informed consent by parent or legal guardian (if \<18 years old) and informed assent if applicable
- Subject and/or parent/legal guardian is willing to be contacted in the future by study staff
- Seen for clinical care at Johns Hopkins since 1/1/2017
- Previously on, currently on, or planning to initiate (within next 6 months) a systemic AD therapy
Exclusion criteria
- Age ≥26 years old at the time of registry enrollment
- Does not speak English
- If \<18 years old, has a primary caretaker who does not speak English
- If \<18 years old, parent/legal guardian is unwilling to sign the written informed consent
- Is a foster child
- Has not received clinical care at Johns Hopkins since 1/1/2017
Where it is running
1 location listed across 1 US state.
- Johns Hopkins University - Baltimore, Maryland, United States